About Protein SSXT
Protein SSXT (SS18) is a protein
from Homo sapiens identified by UniProt accession
Q15532, 418 residues long.
MolForge cross-references it against 0 known binders and
184 disease associations.
Target properties
| Protein name | Protein SSXT |
| UniProt accession | Q15532 |
| Gene | SS18 |
| Organism | Homo sapiens |
| Length | 418 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (184)
Diseases linked to this target (Open Targets).
- synovial sarcoma · score 0.39
- rhabdomyosarcoma · score 0.37
- malignant peripheral nerve sheath tumor · score 0.37
- Pleural Sarcomatoid Mesothelioma · score 0.37
- Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor · score 0.37
- monophasic synovial sarcoma · score 0.37
- leiomyosarcoma · score 0.37
- neurofibroma · score 0.37
- Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation · score 0.37
- undifferentiated pleomorphic sarcoma · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q15532-F1 | alphafold | PREDICTED | 53.70 | — |
Amino-acid sequence (418 residues)
MSVAFAAPRQ RGKGEITPAA IQKMLDDNNH LIQCIMDSQN KGKTSECSQY QQMLHTNLVY LATIADSNQN MQSLLPAPPT QNMPMGPGGM NQSGPPPPPR SHNMPSDGMV GGGPPAPHMQ NQMNGQMPGP NHMPMQGPGP NQLNMTNSSM NMPSSSHGSM GGYNHSVPSS QSMPVQNQMT MSQGQPMGNY GPRPNMSMQP NQGPMMHQQP PSQQYNMPQG GGQHYQGQQP PMGMMGQVNQ GNHMMGQRQI PPYRPPQQGP PQQYSGQEDY YGDQYSHGGQ GPPEGMNQQY YPDGHNDYGY QQPSYPEQGY DRPYEDSSQH YYEGGNSQYG QQQDAYQGPP PQQGYPPQQQ QYPGQQGYPG QQQGYGPSQG GPGPQYPNYP QGQGQQYGGY RPTQPGPPQP PQQRPYGYDQ GQYGNYQQ
Explore Protein SSXT with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets